Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
579 DKK | +1.40% | -2.69% | +24.84% |
22/04 | U.S. Futures, European Stocks Rise | DJ |
16/04 | GRI Bio Receives South Korea Patent for Liver Inflammatory Condition Treatments | MT |
Sales 2024 * | 22.01B 3.16B 263B | Sales 2025 * | 22.96B 3.29B 275B | Capitalization | 31.05B 4.45B 371B |
---|---|---|---|---|---|
Net income 2024 * | 1.28B 183M 15.27B | Net income 2025 * | 1.34B 193M 16.07B | EV / Sales 2024 * | 1.19 x |
Net cash position 2024 * | 4.82B 691M 57.6B | Net cash position 2025 * | 3.75B 537M 44.79B | EV / Sales 2025 * | 1.19 x |
P/E ratio 2024 * |
24.4
x | P/E ratio 2025 * |
23.2
x | Employees | 4,449 |
Yield 2024 * |
-
| Yield 2025 * |
0.61% | Free-Float | 99.68% |
Latest transcript on NKT A/S
1 day | +1.40% | ||
1 week | -2.69% | ||
Current month | +1.58% | ||
1 month | -0.86% | ||
3 months | +20.07% | ||
6 months | +71.30% | ||
Current year | +24.84% |
Managers | Title | Age | Since |
---|---|---|---|
Claes Westerlind
CEO | Chief Executive Officer | 42 | 01/17/01 |
Michael Hjorth
CEO | Chief Executive Officer | 58 | 01/05/01 |
Line Fandrup
DFI | Director of Finance/CFO | 44 | 01/20/01 |
Members of the board | Title | Age | Since |
---|---|---|---|
Jens Due Olsen
CHM | Chairman | 60 | 01/06/01 |
Director/Board Member | 69 | 01/16/01 | |
Andreas Nauen
BRD | Director/Board Member | 59 | 01/17/01 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.05% | 773 M€ | -.--% | - | |
0.02% | 10 M€ | -3.35% | - |
Date | Price | Change | Volume |
---|---|---|---|
26/24/26 | 579 | +1.40% | 104,417 |
25/24/25 | 571 | +0.26% | 129,648 |
24/24/24 | 569.5 | +0.62% | 119,517 |
23/24/23 | 566 | -0.70% | 126,010 |
22/24/22 | 570 | -4.20% | 246,731 |
Delayed Quote Nasdaq Copenhagen, April 26, 2024 at 08:29 pm IST
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+24.84% | 4.45B | |
+4.53% | 149B | |
+34.66% | 130B | |
+19.57% | 130B | |
+12.90% | 62.82B | |
+7.65% | 41.04B | |
+94.65% | 35B | |
+6.26% | 32.1B | |
-9.78% | 32.1B | |
+3.97% | 27.31B |
- Stock Market
- Equities
- NKT Stock